AGN
Pharmaceuticals, Biotechnology & Life Sciences
Argenica Therapeutics
- Short interest
- 0.01%
- +0.01 pp 30d
- as of 3 July 2026
- Reported shorts
- 15.2K
- Shares on issue
- 128.457M
Argenica Therapeutics (AGN) short interest history
Short interest chart
Toggle series, zoom, and compare · ASIC daily, T+4AGN Short Interest History
- 30-day change
- +0.01pp
- 90-day change
- +0.01pp
- 1-year change
- +0.01pp
- All-time high
- 0.01% (July 2026)
- All-time low
- 0.00% (June 2024)
Is AGN heavily shorted?
Not especially: 0.01% short interest is modest by ASX standards. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has AGN's short interest changed recently?
Over the past 30 days Argenica Therapeutics's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.01% of shares on issue.
What is the highest AGN's short interest has been?
Since 2023, Argenica Therapeutics's short interest peaked at 0.01% in July 2026 and bottomed at 0.00% in June 2024.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2023. See our methodology.